Clinical Trials Update: Sept. 30, 2003
Depression Hepatitis Ovarian Cancer
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A research study of an investigational medication for depression. Volunteers who are experiencing a current episode of depression lasting at least 4 weeks but not longer than 2 years may be eligible. Research site located in Shreveport, Louisiana.
A research study of a new oral medication for hepatitis. Volunteers who have a positive hepatitis C antibody test and are genotype 1 with a minimum of 100,000 IU of hepatitis C virus by nucleic acid testing may be eligible. Research sites located throughout the United States.
A research study of an investigational medication for ovarian cancer. Female volunteers age 18 or older who have stage III/IV ovarian cancer and have had elevated levels of CA125 may be eligible. Research site located in Austin, Texas.
Copyright 2003 CenterWatch. All rights reserved.